Strategic partnerships Glooko’s expanding ecosystem with inpatient EndoTool, outpatient platform, mobile app, and remote monitoring (France) presents cross-selling opportunities to integrate diabetes management across care settings and expand enterprise partnerships with hospitals and health systems.

Integrated data Recent integrations such as cloud connectivity with Tandem insulin pumps and EHR pump settings data visualization create a compelling case for SSO-enabled data exchange and streamlined clinical workflows, appealing to health systems seeking reduced manual data handling.

Expansion momentum GestationalCare launch and active attendance at major diabetes education events signal growth in specialized care segments and opportunities to upsell to obstetric and education-focused departments within hospitals and health networks.

Financial scale With substantial funding and mid-market revenue, Glooko targets enterprise hospitals and large health systems; sales teams can focus on mid-to-large accounts seeking glycemic safety improvements, interoperability, and reduced clinician burden.

Security and reliability Emphasis on robust tech stack and security (firewalls, trusted cloud, monitoring tools) positions Glooko as a dependable partner for regulated healthcare buyers prioritizing data governance, uptime, and compliance in digital health deployments.